Relationship between subjective symptoms and trans-telephonic ECG findings in patients with symptomatic paroxysmal atrial fibrillation and flutter

Journal of Cardiology

Volumn 52, Issue 2, 2008, Pages 102-110

  Atarashi, Hirotsugu ^a   Ogawa, Satoshi ^b   Inoue, Hiroshi ^c  

^a NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antiarrhythmic agents; Atrial fibrillation; Atrial flutter; Electrocardiography; Subjective symptom; Trans telephonic monitoring

Indexed keywords

FLECAINIDE; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYMPTOM; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; FISHER EXACT TEST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTIMAL DRUG DOSE; PREDICTIVE VALIDITY; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; TELEPHONE; TREATMENT DURATION;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TELEPHONE;

EID: 52049116369     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.06.006     Document Type: Article

References (17)

1. Brand F.N., Abbott R.D., Kannel W.B., and Wolf P.A. Characteristics and prognosis of atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 254 (1985) 3449-3453
2. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., Rautaharju P.M., et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74 (1994) 236-241
3. Savelieva I., and Camm A.J. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Intervent Cardiac Electrophysiol 4 (2000) 369-382
4. Flaker G.C., Belev K., Beckman K., Vidaillet H., Korn J., Safford R., et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J 149 (2005) 657-663
5. Atarashi H., Ogawa S., Inoue H., Hamada C., and for the Flecainide Atrial Fibrillation Investigators. Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and/or flutter monitored with trans-telephonic electrocardiography-a multicenter, placebo-controlled, double-blind trial. Circ J 71 (2007) 294-300
6. Anderson J.L., Gilbert E.M., Alpert B.L., Henthorn R.W., Waldo A.L., Bhandari A.K., et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Circulation 80 (1989) 1557-1570
7. Kühlkamp V., Schirdewan A., Stangl K., Homberg M., Ploch M., and Beck O.A. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 36 (2000) 139-146
8. Patten M., Maas R., Karim A., Müller H.W., Simonovsky R., and Meinertz T. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial. J Cardiovasc Electrophysiol 17 (2006) 1216-1220
9. Hindricks G., Piorkowski C., Tanner H., Kobza R., Gerds-Li J.H., Carbucicchio C., et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation. Relevance of asymptomatic arrhythmia recurrence. Circulation 112 (2005) 307-313
10. Senatore G., Stabile G., Bertaglia E., Donnici G., De Simone A., Zoppo F., et al. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 45 (2005) 873-876
11. Murgatroyd F.D., Gibson S.M., Baiyan X., O'Nunain S., Poloniecki J.D., Ward D.E., et al. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Circulation 99 (1999) 2765-2770
12. Page R.L., Wilkinson W.E., Clair W.K., McCarthy E.A., and Pritchett E.L.C. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89 (1994) 224-227
13. Strickberger S.A., Ip J., Saksena S., Curry K., Bahnson T.D., and Ziegler P.D. Relationship between atrial tachyarrhythmia and symptoms. Heart Rhythm 2 (2005) 125-131
14. Page R.L., Tilsch T.W., Connolly S.J., Schnell D.J., Marcello S.R., Wilkinson W.E., et al. Asymptomatic or "silent" atrial fibrillation. Frequency in untreated patients and patients receiving azimilide. Circulation 107 (2003) 1141-1145
15. Bhandari A.K., Anderson J.L., Gilbert E.M., Alpert B.L., Henthorn R.W., Waldo A.L., et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J 124 (1992) 381-386
16. Lévy S., Maarek M., Coumel P., Guize L., Lekieffre J., Medvedowsky J.L., et al. Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA Study. Circulation 99 (1999) 3028-3035
17. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.